OR WAIT 15 SECS
The Future of Ethylene Oxide Sterilization
By Stephen Conviser
Ten years ago, Central Service Managers had two choices for sterilizing steam-sensitivemedical devices: 12-88, a non-flammable mix of EO in CFC-12, and pure, flammable EO. AsEO/CFC-12 was phased out by the EPA (CFC-12 is implicated in depleting stratosphericozone), alternative low-temperature sterilizers were introduced to the CS Manager. Today,the CS Manager must decide how best to use three different types of low-temperature gassterilizers: 1) pure EO (provided by STERIS and 3M Health Care); 2) non-flammable EO/HCFCblends that replaced 12-88 (sold under the brand names of Penn Gas 2 and Oxyfume, used insterilizers provided by Getinge/Castle and STERIS); and 3) vapor phase hydrogen peroxideplasma (sold under the brand name STERRADÂ®).
Many CS Managers plan to use EO into the indefinite future and several plan to use thisworkhorse sterilant more. This article will discuss why so many managers feel they need EOand highlights two EO sterilizer changes that will help CS Managers.
EO is a basic chemical. People use 17 billion pounds per year worldwide. Some of theproducts made from EO include textiles, detergents, and anti-freeze. Nearly half of allmedical devices sterilized by device manufacturers are sterilized by EO. The other half issterilized by radiation. The uses of EO continue to grow with the economy.
The average hospital has always used less than 500 pounds per year of EO sterilant(5,000 pounds per year of gas blends). But, in spite of small volume use, hospitalreprocessors have always considered EO to be vital. Answering some key questions about EOexplains its singular role and predicts its direction for future use.
EO sterilizes by alkylation. EO substitutes for hydrogen atoms on molecules needed tosustain life, and, by attaching to these molecules, EO stops these molecules' normallife-supporting functions. Some of the key molecules that EO disrupts are proteins andDNA. Under low-temperature sterilizing conditions, so much EO is used that this disruptionproves lethal to microbial life.
The other low-temperature gas sterilizing process, plasma, uses a super-oxidizer,hydrogen peroxide. Super-oxidizers destroy life-supporting molecules. Not much is neededto be lethal. But, super-oxidizers react with many other molecules in the medical devicesand packaging; hence, to avoid damage to the device, they are not used with certainsensitive materials and are used only in small amounts with other materials.
Efficacy--The ability to kill microbes in difficult to reach places.
The Sterility Assurance Level [SAL] for EO sterilizers is 10-6. This meansthat after sterilization, there is a one in a million chance that a live microbe is in thesterilized load. EO sterilizers are validated using an "overkill" procedure.Sterilizer manufacturers measure how long it takes to reach an SAL of 10-6,then we expose the load for twice that time.1
To prove efficacy, it is not enough to know how long it takes EO to kill microbes butalso how long it takes to penetrate the types of barriers that a typical sterilizer loadmay contain. For this reason, all EO efficacy testing is done in barrier packs. An exampleis the AAMI challenge pack, in which two biological indicators (BIs) each contained in asyringe are placed in the middle of 12 layers of cotton towels, wrapped in two wrappers.Also, to absorb and divert EO from the syringes, the pack contains a plastic airway and10" of latex tubing.2 Often for day-to-day operations, the hospital usessimpler challenges such as BIs in syringes.
Residues--The Need to Aerate
After exposure to EO, the medical devices and packaging contain trace amounts of EO. Forpatient and worker safety, operators need to aerate the devices until the EO residues arereduced to safe levels.
Long Cycle Time
Because operators need time to ensure good efficacy and to aerate the devices, the EOcycle can be as long as 15 hours, but improved cycles reduce this time.
Best Possible Material Compatibility and Penetrability|
EO at sterilizing temperatures has shown that it kills microbes in hard-to-reach andhard-to-clean spots, and it does so with no damage to devices.
Health and Safety
The hospital must manage the toxic and reactive hazards of sterilizing chemicals.Chemicals that kill microbes can harm people.
All chemical sterilizer users need to comply with the following regulations andto meet published guidelines:
Ethylene oxide users comply with a special EO Rule (29 CFR 1910.1047). Administered byOSHA since 1984, it references rules for other chemicals but provides more comprehensiverequirements for risk management.3
Manage EO Flammability
EO burns easily. The hospital may use pure EO (3M Health Care and STERIS 3017) or anon-flammable blend of EO, usually in fluorocarbons (Oxyfume 2002 and Penn Gas 2). Pure EOmust be used in small chambers 4 to 8 cubic feet, must be operated under vacuum, and canonly be supplied in small cartridges (about 100 grams).
Non-flammable blends may be used in large chambers and supplied in large cylinders.About 70% of all EO used by hospitals is used as non-flammable blends. Significant changesare underway in blend sterilizers.
First, they can get the best possible SAL with EO. Side-by-side studies (EO blends vs.pure EO vs. hydrogen peroxide plasma) show higher safety margins offered by EO with thebest SALs achieved by the EO blend sterilizers.4-5 EO sterilizers use anoverkill cycle to achieve an SAL of 10-6, which operators confirm by a BIchallenge in a barrier pack in every sterilizer load.
Secondly, those who use the blend sterilizers rely on a "workhorse" processwhere there are almost no material limits, almost no device configuration limits, no sizelimits, high load limits (for chamber sizes up to 70 cubic feet), and for large chambers,the highest per cycle through-put with the greatest variety of devices.
Assuming that devices returned for reprocessing are easily separated and sorted, thehospital can choose not to use EO for the following:
EO blend sterilizers are being made better in two ways: improved cycles and a newsterilant blend that meets the next century's regulatory needs. Improved cycles are beingintroduced now in the US, and the new sterilant blend is now being introduced in Europeand Canada.
The hospital community has long felt that EO blend cycles could be improved. But, witha heavy focus on complying with the OSHA EO Rule over the last 15 years, few resourceshave been available to improve the sterilizer as a sterilizer. Indeed, two obviousimprovements can readily be made: the sterilizer can use less gas and operate with shortercycles. Equipment change would be minimal, and the new cycles can be validated in a verystraightforward manner.
Gas use can be reduced. In fact, medical device makers use less gas per cycle than inthe past. Lower gas use has been validated for EO/CO2 sterilizers.Controlled laboratory studies show how to use less gas. Finally, less gas use has beenvalidated in hospital sterilizers using the current EO/HCFC blends.
Operators have lowered gas use in three simple steps:
Following these steps, gas use per cycle was reduced 25%. If we are to reduce cycletime, we must reduce aeration time. It accounts for over 80% of the total time to operatea blend sterilizer. From what medical device manufacturers have learned about improvedaeration and from what is known about gas processes, we know of three ways to improveaeration.
Raise aeration temperature. For every 18Âº F increase in temperature, aerationtime is reduced about 50%. To avoid device damage, aeration temperatures should be lessthan 140Âº F.
Pulse continuously from vacuum to atmospheric (approximately) pressure and back.This helps sweep EO from the chamber. The rate of pulsing will be limited by equipmentcapability. No pulses have been reported at times less than 15 minutes, time fromatmospheric pressure to vacuum back to atmospheric pressure.
Aerate longer at vacuum than at atmospheric or higher pressures. At vacuum thereis little to no air or water molecules to block and slow the rate of EO degassing from themedical device.
Using less gas to sterilize reduces the amount of EO to be degassed. But it doesn'treduce total cycle time. Using 25% less EO to sterilize reduces aeration time about 5 to10%--a savings of one hour in aeration. But, to use 25% less EO, we must increase exposuretime by one hour. Using less EO results in a net trade-off of zero in reducing total cycletime, one hour more exposure offset by one hour less aeration.
We validate shorter aeration times, so we know we can reduce aeration time safelywithout leaving higher EO residues on the medical devices. The validation occurs in thefollowing manner. First, measure the residue left after aeration, using the current longcycle. We measure residue on a hard-to-aerate material, PVC tubing. Although PVC is notgenerally in re-usable devices, medical device manufacturers have found it to be one ofthe toughest of all device materials to aerate. PVC tubing is placed in the chamber at thesame locations we use barrier packs to measure efficacy. Second, measure residues on thePVC tubing using shorter aeration times. Third, if the residue left after short cycleaeration is no more than the residue left after the current aeration, we have demonstratedthat the short cycle did not leave a higher residue and worked as well as the currentcycle. Note: Residues are measured by an outside laboratory that specializes in suchprocedures.
Some service companies now offer short cycle upgrades. Upgrade costs range from $5,000to $20,000. The hospital must validate these service company cycles. One firm isdeveloping new control systems and seeking an FDA 510K so that they may offer them to anyUS hospital. The hospital would not have to validate a 510K cycle. These systems areexpected to cost $15,000 to $20,000 installed. For either type of upgrade, the hospitalcan save 25% on gas cost, can double the number of cycles run each day, or can start thesterilizer late in the afternoon, knowing that sterilized devices will be ready for earlymorning surgery.
21st Century Blend--SterifloÂ® Sterilant Gas
Oxyfume 2002 and Penn Gas 2 blends use HCFCs which have 0.02+ Ozone DepletionPotential (ODP), a measure of a chemical's potential to deplete the stratospheric ozonethat protects life on earth. The ODP is 2% of the ODP of 12-88 sterilant that was phasedout in 1995. For this reason, under the Clean Air Act, hospitals may continue to use thesematerials in existing sterilizers until the year 2030 and may buy new sterilizers withthese materials until the year 2015.
A new blend, with the brand name, Steriflo, has been developed. It has zero ODP and,under the Clean Air Act, may be used into the indefinite future with no expectation of aphase-out date. The new blend uses HFCs to control EO flammability.
The HFC blend offers other benefits over the current blends. It contains about 5% moreethylene oxide, so no matter what cycle the hospital uses, it can use about 5% less gas.In cycle studies with barrier packs, Steriflo sterilizes much faster than the currentblends, meaning the operator can sterilize with less exposure time or in the same timewith less gas, and Steriflo can be substituted in the same sterilizer with few equipmentchanges.
Steriflo provides the same benefits now available to the sterilizer operator. Thissterilant gas offers:
Steriflo is now being validated in Europe and the US by medical device manufacturersand sterilizer makers. First conversions will begin in Canada and Europe. US use of thenew blend will not start until it has been validated and is registered as a pesticide bythe EPA. Expected date release for this product is 2001 to 2002.
Hospitals will continue to use EO sterilization because it sterilizes in a penetratingfashion. Hospitals will continue to use blend sterilizers because EO blend sterilizershave shown the good sterility assurance and high throughput. Improved cycles make theblend sterilizer both economic and flexible. The 21st Century Blend EO/HFC furtherenhances sterilizer performance while its zero ozone depleting properties make it asterilant for the future. Most importantly, it is not subject to the 2030 phase-out datethat affects the current blend sterilants.
Steve Conviser is the sterilant manager at Honeywell (Morristown, NJ).
For references, access the ICT Web site.
For a complete list of references click here